Kim De Leeneer

4.3k citations

29 papers · 697 indexed · h-index 17

Co-authors: Kathleen Claes Bruce Poppe Anne De Paepe Ilse Coene Paul Coucke Jan Hellemans Machteld Baetens Wim Van Criekinge
Topics: BRCA gene mutations in cancer (9 papers)Cancer Genomics and Diagnostics (9 papers)DNA Repair Mechanisms (7 papers)
Cited by: Cancer Research Genetics Molecular Biology
Journals: Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaGastroenterology
Partner nations: Belgium United States South Africa

In The Last Decade

Kim De Leeneer

28 papers receiving 689 citations

Peers

Countries citing papers authored by Kim De Leeneer

Since Specialization

Citations

This map shows the geographic impact of Kim De Leeneer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim De Leeneer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim De Leeneer more than expected).

Fields of papers citing papers by Kim De Leeneer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim De Leeneer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim De Leeneer. The network helps show where Kim De Leeneer may publish in the future.

Co-authorship network of co-authors of Kim De Leeneer

This figure shows the co-authorship network connecting the top 25 collaborators of Kim De Leeneer. A scholar is included among the top collaborators of Kim De Leeneer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim De Leeneer. Kim De Leeneer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Performance Evaluation of Three DNA Sample Tracking Tools in a Whole Exome Sequencing Workflow 2022 ·Molecular Diagnosis & Therapy ·(unknown),Céline Helsmoortel,Pieter‐Jan Volders,(unknown),(unknown),Jo Vandesompele,Frauke Coppieters,Kim De Leeneer,Steve Lefever	2
2	Noncoding Aberrations in Mismatch Repair Genes Underlie a Substantial Part of the Missing Heritability in Lynch Syndrome 2022 ·Gastroenterology ·Iris te Paske,Arjen R. Mensenkamp,Kornelia Neveling,Stéphanie Baert‐Desurmont,Kathleen Claes,Kim De Leeneer,(unknown),(unknown),Rachel S. van der Post,(unknown),Tjakko J. van Ham,Anja Wagner,Mirjam M. de Jong,Edward M. Leter,Maartje Nielsen,Nicoline Hoogerbrugge,Marjolijn J. L. Ligtenberg,Richarda M. de Voer	17
3	CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping 2021 ·Proceedings of the National Academy of Sciences ·Thomas Naert,(unknown),(unknown),(unknown),(unknown),Matt van de Rijn,(unknown),Benjamin A. Alman,Paul Coucke,Kim De Leeneer,Christian Vanhove,Savvas N. Savvides,David Creytens,Kris Vleminckx	9
4	Dealing with Pseudogenes in Molecular Diagnostics in the Next Generation Sequencing Era 2021 ·Methods in molecular biology ·Kathleen Claes,Toon Rosseel,Kim De Leeneer	10
5	Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2 -associated hereditary breast and ovarian cancer reveals multiple co-acting second hits 2018 ·Cancer Letters ·Mattias Van Heetvelde,Mieke Van Bockstal,Bruce Poppe,Kathleen Lambein,Toon Rosseel,Lilit Atanesyan,Dieter Deforce,Ivo Van Den Berghe,Kim De Leeneer,Jo Van Dorpe,Anne Vral,Kathleen Claes	12
6	Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei 2017 ·DNA repair ·Flavia Zita Francies,(unknown),Janet L. Poole,Kim De Leeneer,Ilse Coene,(unknown),Hélène A. Poirel,Bénédicte Brichard,S. Vermeulen,Anne Vral,Jacobus Slabbert,Kathleen Claes,Ans Baeyens	14
7	Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay 2017 ·Oncology Reports ·(unknown),Julie Depuydt,Tom Van Maerken,Bruce Poppe,Fransiska Malfait,Tim Van Damme,(unknown),Gianpaolo Perletti,Kim De Leeneer,Kathleen Claes,Anne Vral	23
8	Evaluation of relative quantification of alternatively spliced transcripts using droplet digital PCR 2017 ·SHILAP Revista de lepidopterología ·Mattias Van Heetvelde,Wouter Van Loocke,Wim Trypsteen,(unknown),Katrien Vanderheyden,(unknown),Jo Vandesompele,Kim De Leeneer,Kathleen Claes	15
9	Novel FRMD7 Mutations and Genomic Rearrangement Expand the Molecular Pathogenesis of X-Linked Idiopathic Infantile Nystagmus 2015 ·Investigative Ophthalmology & Visual Science ·(unknown),Miriam Bauwens,Sophie Walraedt,Patricia Delbeke,Julie De Zaeytijd,P. Kestelyn,Françoise Meire,Sandra Janssens,Caroline Van Cauwenbergh,Hannah Verdin,(unknown),Prasoon Kumar Thakur,Frauke Coppieters,Kim De Leeneer,(unknown),Bart P. Leroy,Elfride De Baere	23
10	Targeted resequencing and variant validation using pxlence PCR assays 2015 ·SHILAP Revista de lepidopterología ·Frauke Coppieters,Kimberly Verniers,Kim De Leeneer,Jo Vandesompele,Steve Lefever	2
11	Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer 2015 ·Advances in experimental medicine and biology ·Kim De Leeneer,Kathleen Claes	34
12	BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer 2015 ·BMC Cancer ·Flavia Zita Francies,(unknown),Kim De Leeneer,Alan C. Cairns,(unknown),Sarah Nietz,Herbert Cubasch,Bruce Poppe,Tom Van Maerken,(unknown),Ilse Coene,(unknown),Jacobus Slabbert,Anne Vral,Amanda Krause,Ans Baeyens,Kathleen Claes	40
13	Next Generation Sequencing to Determine the Cystic Fibrosis Mutation Spectrum in Palestinian Population 2015 ·Disease Markers ·(unknown),(unknown),Kim De Leeneer,Wouter Steyaert,Karen De Pauw,Anne De Paepe,Kathleen Claes,Tamer Essawi,Paul Coucke	8
14	Dealing with Pseudogenes in Molecular Diagnostics in the Next-Generation Sequencing Era 2014 ·Methods in molecular biology ·Kathleen Claes,Kim De Leeneer	25
15	Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families 2012 ·British Journal of Cancer ·(unknown),Kim De Leeneer,G Michils,Nancy Hamel,Eva Tomiak,Bruce Poppe,Karin Leunen,Eric Legius,Andrew Y. Shuen,(unknown),Jocelyne Arseneau,Patricia N. Tonin,Gert Matthijs,Kathleen Claes,Marc Tischkowitz,William D. Foulkes	32
16	Analysis of the Novel Fanconi Anemia GeneSLX4/FANCPin Familial Breast Cancer Cases 2012 ·Human Mutation ·(unknown),Saskia E. van Mil,Gerry P. Crossan,Nelly Sabbaghian,Kim De Leeneer,Bruce Poppe,Muriel A. Adank,Gilles Thomas,Henk M.W. Verheul,Hanne Meijers‐Heijboer,Johan P. de Winter,Kathleen Claes,Marc Tischkowitz,Quinten Waisfisz	15
17	Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations 2011 ·Human Mutation ·Kim De Leeneer,Jan Hellemans,Joachim De Schrijver,Machteld Baetens,Bruce Poppe,Wim Van Criekinge,(unknown),Paul Coucke,Kathleen Claes	53
18	Practical Tools to Implement Massive Parallel Pyrosequencing of PCR Products in Next Generation Molecular Diagnostics 2011 ·PLoS ONE ·Kim De Leeneer,Joachim De Schrijver,Lieven Clement,Machteld Baetens,Steve Lefever,Sarah De Keulenaer,Wim Van Criekinge,Dieter Deforce,Filip Van Nieuwerburgh,Sofie Bekaert,Filip Pattyn,Bram De Wilde,Paul Coucke,Jo Vandesompele,Kathleen Claes,Jan Hellemans	34
19	Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes 2011 ·Human Mutation ·Machteld Baetens,Lut Van Laer,Kim De Leeneer,Jan Hellemans,Joachim De Schrijver,(unknown),Marjolijn Renard,Hal Dietz,Ronald V. Lacro,Björn Menten,Wim Van Criekinge,Julie De Backer,Anne De Paepe,Bart Loeys,Paul Coucke	61
20	Analysing 454 amplicon resequencing experiments using the modular and database oriented Variant Identification Pipeline 2010 ·BMC Bioinformatics ·(unknown),Kim De Leeneer,Steve Lefever,(unknown),Filip Pattyn,Filip Van Nieuwerburgh,Paul Coucke,Dieter Deforce,Jo Vandesompele,Sofie Bekaert,Jan Hellemans,Wim Van Criekinge	14

About Kim De Leeneer

Kim De Leeneer is a scholar working on Cancer Research, Genetics and Molecular Biology, having authored 29 papers that have together received 697 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (9 papers), Cancer Genomics and Diagnostics (9 papers) and DNA Repair Mechanisms (7 papers). The work is most often cited by research in Cancer Research (212 citations), Genetics (342 citations) and Molecular Biology (409 citations). Kim De Leeneer has collaborated with scholars based in Belgium, United States and South Africa. Frequent co-authors include Kathleen Claes, Bruce Poppe, Anne De Paepe, Ilse Coene, Paul Coucke, Jan Hellemans, Machteld Baetens, Wim Van Criekinge, Joachim De Schrijver and Anne Vral. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact